COVID-19 Vaccine Manufacturing: Moderna CEO Worries Most About Raw Materials

 
• By Brenda Sandburg

Moderna's Bencal and Merck Vaccine head Markels discuss the difficulties in scaling up manufacturing capacity for vaccine candidates at BIO plenary session; CEPI CEO says his organization can help facilitate pairing of vaccine development partners.

covid-19 affects Manufacturing and leads to a crash and crisis, 3d illustration
COVID-19 vaccine developers face manufacturing scale up challenges

More from Vaccines

More from Pink Sheet